Program Modules
FACULTY
Dr. Kevin Winthrop
Oregon Health & Science University, Portland, OR, USA
Kevin L. Winthrop is Professor of Infectious Diseases and Ophthalmology at the School of Medicine and a Professor of Public Health at the OHSU-PSU School of Public Health at Oregon Health & Science University (OHSU) in Portland, OR, USA.
Dr. Winthrop received his undergraduate degree in biology from Yale University, New Haven, CT, USA and his MD from OHSU. He completed his internal medicine residency training at Legacy Emanuel Hospital, Portland, OR. He then completed an infectious disease epidemiology fellowship at the US Centers for Disease Control and Prevention. In 2003, Dr. Winthrop was conferred a Master in Public Health from the University of California, Berkley, CA, USA. In 2006, Dr. Winthrop returned to OHSU as Assistant Professor before progressing to his current appointment in 2017.
A former infectious disease epidemiologist in the Division of Tuberculosis Elimination at the US Centers for Disease Control and Prevention (CDC), Dr Winthrop has co-authored over 300 publications, many regarding the epidemiologic and clinical aspects of opportunistic infections associated with immune- mediated inflammatory diseases, particularly those related to biologic immunosuppressive therapies.
As a primary or senior investigator in many clinical or epidemiologic studies in these fields, he has collaborated closely with the rheumatology community in the evaluation and prevention of opportunistic infections. In addition, he is also a member of the graduate faculty at OHSU, where he mentors public health students, medical students, and physicians in post-graduate training.
Selection of current projects:
- The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF Users Trial
- The Safety and Effectiveness of the VaricElla zosteR VaccinE (VERVE) in Anti-TNF and Abatacept Users Trial – substudy of VERVE
- Psoriasis standing cohort using Medicare database; evaluation of outcomes and drug safety for individuals with psoriasis and psoriatic arthritis
- Evaluation of co-morbidities in patients with ankylosing spondylitis
- Evaluation of the safety of ustekinumab and secukinumab in individuals with Hepatitis B or C
Selection of recent publications:
- Winthrop KL, Weinblatt ME, Bathon J, et al. Unmet need in rheumatology: Reports from the Targeted Therapiesmeeting 2019. Ann Rheum Dis. 2020;79:88-93.
- Winthrop KL, Baddley J, Chen L, et al. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA. 2013;309:887-895.
- Winthrop KL, Bingham CO, 3rd, Komocsar WJ, et al. Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: Results from a long-term extension trial substudy. Arthritis Res Ther. 2019;21(1):102.
- Winthrop KL, Saag K, Cascino MD, et al. Long-term safety of rituximab in rheumatoid arthritis: Analysis from the SUNSTONE registry. Arthritis Care Res(Hoboken). 2018;71(8):993-1003.
FACULTY PRESENTER
Tami L. Bach, MD, PhD
Clinical Assistant Professor of Medicine
Penn Comprehensive Hemophilia Program
Penn Blood Disorders Center
The University of Pennsylvania
Philadelphia, PA
Tami L. Bach, M.D., Ph.D., is Board Certified in both Hematology and Oncology. Dr. Bach graduated cum laude from Villanova University with a major in Biology. She earned a Ph.D. in Molecular Pharmacology and Structural Biology from Thomas Jefferson University, and an M.D. from Jefferson Medical College in 1998 as a Dunglison Scholar. The post-graduate training of Dr. Bach included an Internal Medicine Internship and Residency at Thomas Jefferson University Hospital, and a Hematology-Oncology Fellowship at the Hospital of the University of Pennsylvania.
Dr. Bach served as a former director of the Penn Comprehensive Hemophilia Program and continues to serve as a Clinical Assistant Professor at the Penn Blood Disorders Center. She directs a transition clinic for Penn Hemophilia, which she started in Woodbury Heights, NJ.
Dr. Bach also serves the community in practice at The Minniti Center for Medical Oncology and Hematology. Her practice services the new Inspira Network in Mullica Hill, Elmer, and Vineland. Dr. Bach has integrated her skills of basic science research and knowledge of translational research into dedicated clinical care in the field of Hematology-Oncology.
